✨
AI Summary
- A patent dispute over CRISPR gene-editing technology involves MIT and UC Berkeley.
- Feng Zhang of MIT secured patent claims against UC Berkeley's Jennifer Doudna.
- The conflict highlights the high stakes and competition in biotech innovation.